Karbis

Candesartan cilexetil, the active ingredient in Karbis, is a Angiotensin II receptor blocker presented as an oral tablet for oral use. It treats hypertension and heart failure in adult patients.

GNH USA supplies Karbis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Karbis is an Angiotensin II receptor blocker used to manage conditions related to the renin‑angiotensin system.

Hypertension: lowers blood pressure and reduces risk of cardiovascular events. Heart failure: improves symptoms, functional capacity and reduces hospitalisation. Diabetic nephropathy: slows progression of renal disease and reduces proteinuria.

Common Side Effects: - Dizziness or light‑headedness. - Headache. - Fatigue. - Abdominal discomfort. - Upper respiratory tract infection. - Back pain.

Serious or Rare Side Effects: - Angioedema (swelling of face, lips, tongue). - Severe hypotension. - Hyperkalemia (elevated potassium levels). - Acute kidney injury. - Hepatic dysfunction. - Myocardial infarction (rare).

Before initiating therapy, clinicians should assess patient history and monitor relevant parameters.

Monitor blood pressure: adjust dose to avoid hypotension. Check renal function: evaluate serum creatinine and eGFR regularly. Assess electrolytes: watch for hyperkalemia, especially with potassium‑sparing agents. Avoid in severe hepatic impairment: limited data on safety. Pregnancy caution: use only if benefits outweigh risks. Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Candesartan may interact with several medicines that affect renal function, potassium balance or blood pressure.

Major Interactions (Avoid): - Concomitant use with aliskiren in diabetic patients: increased risk of renal impairment. - Potassium‑sparing diuretics or supplements: risk of severe hyperkalemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors: combined use may raise angioedema risk. - NSAIDs: may diminish antihypertensive effect and impair renal function. - Lithium: candesartan can raise lithium levels, requiring monitoring.